Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 10 hours ago

PSUSA/00000736/202509

about 10 hours ago

PSUSA/00000736/202509

PSUSA/00000669/202512

about 10 hours ago

PSUSA/00000669/202512

Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of authorisation: 29/09/2023, Revision: 1, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of...

Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 21, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation...

Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Date of authorisation: 26/03/2021, Revision: 10, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Date of authorisation...

Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 22, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation...

Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 15, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium...

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 98, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 5, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of...

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 5, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation...

Human medicines European public assessment report (EPAR): Signifor, pasireotide, Date of authorisation: 24/04/2012, Revision: 16, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Signifor, pasireotide, Date of authorisation...

Human medicines European public assessment report (EPAR): Iqirvo, elafibranor, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Iqirvo, elafibranor, Date of authorisation...